Trademarkia Logo

Australia

AU$
REBUS BIOSYSTEMS
Cancelled: Cancelled at the request of IB

Last updated on 15 Jan 2024

Owner Info

REBUS BIOSYSTEMS, INC.

2255 MARTIN AVENUE, SUITE F

SANTA CLARA CA 95050, UNITED STATES OF AMERICA

Serial Number

2188877 filed on 12 Apr 2021

Correspondent

Carla B. Oakley

Morgan, Lewis & Bockius LLP,,

One Market Street,,

UNITED STATES OF AMERICA

REBUS BIOSYSTEMS

Classification Information


Class [001]
Reagents, oligonucleotide probes, buffer solutions and antibodies, all used for scientific research, genomics, imaging and analysis of genes, molecule Read More

Class [009]
Laboratory equipment, namely, devices for imaging and analysis of genes, molecules and cells; recorded and downloadable computer software used for the Read More

Class [042]
Providing research services for others in the fields of genomics, transcriptomics and proteomics.

Class [045]
Licensing of intellectual property in the fields of genomics, transcriptomics, proteomics, and imaging and analysis of genes, molecules and cells.

Mark Details


Serial Number

2188877

Registered On

12 Apr 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Oct 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
15th Jan 2024Status change to Voided
15th Sept 2021International Registration in Australia Protected correspondence sent
14th Sept 2021IP Right Registration Published
14th Sept 2021Status change to Registered/Protected
8th Jul 2021Application Accepted correspondence sent
7th Jul 2021IP Right has been Examined
7th Jul 2021IP Right Acceptance Published
7th Jul 2021Status change to Accepted
2th Jul 2021Awaiting examination
2th Jul 2021Examination expedited